Topical solution may be less toxic option for patients with noncancerous skin growth

(George Washington University) A team of researchers at the GW School of Medicine and Health Sciences compared the toxicological impact of cryosurgery with an FDA-approved topical 40 percent hydrogen peroxide solution (A-101) for the treatment of seborrheic keratosis, in human skin equivalents derived from darker skin types. The findings were recently published in the Journal of the American Academy of Dermatology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news